CIK: 0001727492 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $427,996 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORPORATION | 10,360,945 | $124,331 | 29.0% | $5.57 | +138.3% | COM NEW | 53635D202 |
| — | ALIMERA SCIENCES INC | 16,835,154 | $93,603 | 21.9% | $3.09 | — | COM NEW | 016259202 |
| ANIK | ANIKA THERAPEUTICS INC | 1,435,993 | $36,374 | 8.5% | $25.57 | +1.3% | COM | 035255108 |
| EXEL | EXELIXIS INC | 1,525,730 | $34,283 | 8.0% | $19.42 | +14.2% | COM | 30161Q104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 4,598,737 | $28,420 | 6.6% | $5.54 | -0.3% | COM | 09058V103 |
| — | VERONA PHARMA PLC | 1,843,756 | $26,661 | 6.2% | $16.60 | — | SPONSORED ADS | 925050106 |
| EOLS | EVOLUS INC | 2,167,790 | $23,521 | 5.5% | $9.79 | +25.7% | COM | 30052C107 |
| AGIO | AGIOS PHARMACEUTICALS INC | 514,711 | $22,194 | 5.2% | $23.62 | +52.8% | COM | 00847X104 |
| ENTA | ENANTA PHARMACEUTICALS INC | 1,042,889 | $13,526 | 3.2% | $13.28 | +1.7% | COM | 29251M106 |
| MLYS | MINERALYS THERAPEUTICS INC | 745,758 | $8,725 | 2.0% | $12.59 | 0.0% | COM | 603170101 |
| — | Y-MABS THERAPEUTICS INC | 582,078 | $7,032 | 1.6% | $6.79 | — | COM | 984241109 |
| NBP | I MAB | 3,374,791 | $5,636 | 1.3% | $1.71 | — | SPONSORED ADS | 44975P103 |
| OTLK | OUTLOOK THERAPEUTICS INC | 500,000 | $3,690 | 0.9% | $8.09 | -0.7% | COM | 69012T305 |